Calidi Biotherapeutics Inc (CLDI)

Sector:
FINANCE
Industry:
GENERAL FINANCE
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
William J. Weber
Employees:
11110 SUNSET HILLS ROAD #2278, RESTON, VA 20190
202-503-9255

First Light Acquisition Group, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and headquartered in Reston, Virginia.

Data derived from most recent annual or quarterly report
Market Cap 93.438 Million Shares Outstanding28.75 Million Avg 30-day Volume 192.825 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.29
Price to Revenue0.0 Debt to Equity0.0477 EBITDA-10.433 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value147.655 Million
Current Ratio0.097 EPS Growth0 Quick Ratio0.082
1 Yr BETA 0.0664 52-week High/Low 13.79 / 2.8 Profit Margin0.0
Operating Cash Flow Growth0.0 Free Cash Flow to Firm (FCFF) TTM 0 Free Cash Flow to Equity (FCFE) TTM-3.133 Million
Altman Z-Score3.5002
View SEC Filings from CLDI instead.

View recent insider trading info

Calidi Biotherapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CLDI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLDI

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HUDSON BAY CAPITAL MANAGEMENT LP

GERBER SANDER

  • 10% Owner
 0 2023-09-12 2

SCHOENECK JAMES A

  • Director
 99,758 2023-09-12 1

NG GEORGE K

  • Director
 28,092 2023-09-12 1

KALAJIAN TONY T CHIEF ACCTG OFFICER, INT. CFO

  • Officer
 278,790 2023-09-12 1

PATEL AMISH VP OF TECHNICAL OPERATIONS

  • Officer
 29,303 2023-09-12 1

MINEV BORIS RADOSLAVOV INTERIM CHIEF MEDICAL OFFICER

  • Officer
 424,458 2023-09-12 1

FERNANDEZ SANTIDRIAN ANTONIO SVP, GLOBAL HEAD OF R&D

  • Officer
 327,788 2023-09-12 1

THESING STEPHEN CHIEF BUSINESS OFFICER

  • Officer
 471,544 2023-09-12 1

CAMPBELL WENDY PIZARRO CAO, CLO

  • Officer
 162,374 2023-09-12 1

SANS DAVID CHIEF OF CORPORATE DEVELOPMENT

  • Officer
 18,314 2023-09-12 1

CAMAISA ALLAN CEO, PRESIDENT AND CHAIRMAN

AJC CAPITAL, LLC

JAMIR TRUST

  • Officer
  • Director
  • 10% Owner
 8,964,521 2023-09-12 1

LEE HEEHYOUNG

  • Director
 246,720 2023-09-12 1

LEFTWICH SCOTT

  • Director
 2,378,588 2023-09-12 1

POLAR ASSET MANAGEMENT PARTNERS INC.

  • 10% Owner
 412,800 2022-10-19 1

HUDSON BAY CAPITAL MANAGEMENT LP

  • 10% Owner
 500,000 2022-10-04 2

FIRST LIGHT ACQUISITION GROUP, LLC CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
 0 2022-09-12 0

RUETTGERS MICHAEL C

  • Director
 0 2021-09-09 0

WEBER WILLIAM JOHN CHIEF EXECUTIVE OFFICER

FIRST LIGHT ACQUISITION GROUP, LLC

  • Officer
  • Director
  • 10% Owner
 0 2021-09-09 0

WEBER WILLIAM JOHN CHIEF EXECUTIVE OFFICER

FIRST LIGHT ACQUISITION GROUP, LLC

FLAG SPONSOR MANAGER, LLC

  • Officer
  • Director
  • 10% Owner
 0 2021-09-09 0

ALBER MICHAEL J. CHIEF FINANCIAL OFFICER

  • Officer
 0 2021-09-09 0

TISINGER JEANNE

  • Director
 0 2021-09-09 0

VECCHIOLLA THOMAS A.

  • Director
 0 2021-09-09 0

FALLON WILLIAM

  • Director
 0 2021-09-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HUDSON BAY CAPITAL MANAGEMENT LP - > 10% Owner see footnote

GERBER SANDER - > 10% Owner see footnote

2023-09-14 14:26:46 -0400 2023-09-12 J 500,000 $10.49 d 0 indirect

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 22:15:03 UTC -11.3476 16.6676 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 21:45:04 UTC -11.3476 16.6676 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 21:15:03 UTC -11.3476 16.6676 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 20:45:05 UTC -11.3476 16.6676 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 20:15:04 UTC -11.3476 16.6676 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 19:45:04 UTC -11.3476 16.6676 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 19:15:03 UTC 0.0 0.0 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 18:45:03 UTC 0.0 0.0 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 18:15:03 UTC 0.0 0.0 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 17:45:03 UTC -11.3476 16.6676 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 17:15:04 UTC -11.3476 16.6676 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 16:45:04 UTC -11.3476 16.6676 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 16:15:03 UTC -11.3476 16.6676 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 15:45:04 UTC -11.3747 16.6947 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 15:15:04 UTC -11.3747 16.6947 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 14:45:04 UTC -11.3747 16.6947 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 14:15:04 UTC -11.3747 16.6947 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 13:45:03 UTC -11.6183 16.9383 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 13:15:04 UTC -11.6183 16.9383 100000
CALIDI BIOTHERAPEUTICS INC CLDI 2023-09-29 12:45:05 UTC -11.6183 16.9383 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments